Updated
Updated · The Conversation · Jul 8
Chinese Researchers Clone 1 Rhesus Monkey to Speed Drug Testing
Updated
Updated · The Conversation · Jul 8

Chinese Researchers Clone 1 Rhesus Monkey to Speed Drug Testing

1 articles · Updated · The Conversation · Jul 8

Summary

  • A rhesus monkey was cloned in China in 2024 in a world first, with researchers aiming to create primates physiologically close to humans for faster drug testing.
  • The work used somatic cell nuclear transfer, but mammal cloning remains inefficient because adult cells often fail to fully reset into an embryo-like state.
  • That low success rate has kept cloning expensive and hard to scale, even 30 years after Dolly the sheep was produced only after 277 attempts.
  • Animal welfare advocates challenged the monkey experiment on ethical grounds, arguing the suffering involved may outweigh limited immediate real-world applications.
  • Beyond labs, cloning is now used selectively in livestock, pets and endangered-species conservation, while human reproductive cloning remains broadly barred for safety and ethical reasons.

Insights

With cloning now proven to have a genetic expiry date, is it a dead end for saving endangered species?
As labs pitch 'brainless' human clones for organ harvesting, have we entered a new era of biological exploitation?
With the US and EU treating DNA as a national asset, is the era of global scientific collaboration ending?